Johnson & Johnson Research and Development Expenses 2006-2020 | JNJ

Johnson & Johnson annual/quarterly research and development expenses history and growth rate from 2006 to 2020. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Johnson & Johnson research and development expenses for the quarter ending September 30, 2020 were $2.840B, a 9.27% increase year-over-year.
  • Johnson & Johnson research and development expenses for the twelve months ending September 30, 2020 were $11.359B, a 0.11% increase year-over-year.
  • Johnson & Johnson annual research and development expenses for 2019 were $11.355B, a 5.38% increase from 2018.
  • Johnson & Johnson annual research and development expenses for 2018 were $10.775B, a 1.71% increase from 2017.
  • Johnson & Johnson annual research and development expenses for 2017 were $10.594B, a 15.87% increase from 2016.
Johnson & Johnson Annual Research and Development Expenses
(Millions of US $)
2019 $11,355
2018 $10,775
2017 $10,594
2016 $9,143
2015 $9,046
2014 $8,494
2013 $8,183
2012 $7,665
2011 $7,548
2010 $6,844
2009 $6,986
2008 $7,577
2007 $7,680
2006 $7,125
2005 $6,462
Johnson & Johnson Quarterly Research and Development Expenses
(Millions of US $)
2020-09-30 $2,840
2020-06-30 $2,707
2020-03-31 $2,580
2019-12-31 $3,232
2019-09-30 $2,599
2019-06-30 $2,666
2019-03-31 $2,858
2018-12-31 $3,224
2018-09-30 $2,508
2018-06-30 $2,639
2018-03-31 $2,404
2017-12-31 $3,643
2017-09-30 $2,585
2017-06-30 $2,296
2017-03-31 $2,070
2016-12-31 $2,688
2016-09-30 $2,178
2016-06-30 $2,264
2016-03-31 $2,013
2015-12-31 $2,864
2015-09-30 $2,154
2015-06-30 $2,129
2015-03-31 $1,899
2014-12-31 $2,635
2014-09-30 $2,023
2014-06-30 $2,005
2014-03-31 $1,831
2013-12-31 $2,411
2013-09-30 $2,042
2013-06-30 $1,946
2013-03-31 $1,784
2012-12-31 $2,331
2012-09-30 $1,923
2012-06-30 $1,766
2012-03-31 $1,645
2011-12-31 $2,155
2011-09-30 $1,773
2011-06-30 $1,882
2011-03-31 $1,738
2010-12-31 $1,982
2010-09-30 $1,657
2010-06-30 $1,648
2010-03-31 $1,557
2009-12-31 $2,213
2009-09-30 $1,617
2009-06-30 $1,638
2009-03-31 $1,518
2008-12-31 $2,108
2008-09-30 $1,861
2008-06-30 $1,896
2008-03-31 $1,712
2007-12-31 $2,328
2007-09-30 $1,834
2007-06-30 $1,866
2007-03-31 $1,652
2006-12-31 $2,046
2006-09-30 $1,719
2006-06-30 $1,828
2006-03-31 $1,532
2005-12-31 $2,014
2005-09-30 $1,539
2005-06-30 $1,525
2005-03-31 $1,384
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $421.997B $82.059B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Roche Holding AG (RHHBY) Switzerland $305.169B 0.00
Novartis AG (NVS) Switzerland $218.868B 16.69
Merck (MRK) United States $210.954B 14.45
Pfizer (PFE) United States $203.993B 12.88
AbbVie (ABBV) United States $195.120B 11.28
Eli Lilly (LLY) United States $182.487B 27.61
Novo Nordisk (NVO) Denmark $169.616B 27.08
AstraZeneca (AZN) United Kingdom $134.747B 26.60
Sanofi (SNY) $123.679B 14.70
GlaxoSmithKline (GSK) United Kingdom $96.503B 12.78
Bayer (BAYRY) Germany $59.012B 8.89
H Lundbeck (HLUYY) Denmark $7.210B 12.75
Innoviva (INVA) United States $1.290B 5.89